[1]卓锦蓝,龚先琼.慢性乙型肝炎中医证型研究进展[J].医学信息,2020,33(03):43-45.[doi:10.3969/j.issn.1006-1959.2020.03.013]
　ZHUO Jin-lan,GONG Xian-qiong.Study on TCM Syndromes of Chronic Hepatitis B[J].Medical Information,2020,33(03):43-45.[doi:10.3969/j.issn.1006-1959.2020.03.013]
点击复制

慢性乙型肝炎中医证型研究进展()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年03期
页码:
43-45
栏目:
综述
出版日期:
2020-02-01

文章信息/Info

Title:
Study on TCM Syndromes of Chronic Hepatitis B
文章编号:
1006-1959（2020）03-0043-03
作者:
卓锦蓝; 龚先琼
（1.福建中医药大学第二临床医学院，福建 福州 350122；2.福建中医药大学附属厦门中医院，福建 厦门 361009）
Author(s):
ZHUO Jin-lan1; GONG Xian-qiong2
(1.the Second Clinical Medical College of Fujian University of TraditionalChinese Medicine,Fuzhou350122,Fujian,China;2.Xiamen Traditional Chinese Medicine Hospital,Fujian University of Traditional Chinese Medicine,Xiamen 361009,Fujian,China)
关键词:
慢性乙型肝炎; 中医证型; 理化指标
Keywords:
Chronic hepatitis B; TCM syndrome type; Physical and chemical indicators
分类号:
R259.1
DOI:
10.3969/j.issn.1006-1959.2020.03.013
文献标志码:
A
摘要:
目前慢性乙型肝炎（CHB）的中医辨证分型尚无统一标准，一般认为主要包括湿热内结证、肝郁脾虚证、肝肾阴虚证、瘀血阻络证、脾肾阳虚证5种。近年来，大量研究发现CHB的中医证型与非结合胆红素（IBIL）、总胆红素（TBIL）、γ-谷氨酰转肽酶（GGT）、HBsAg、HBeAg、HBV-DNA、机体免疫状态、细胞因子、肝脏病理及影像学指标存在一定的相关性。本文就CHB的中医证型及其与上述指标的相关性进行综述，旨在为CHB辨证分型的客观化研究提供参考依据，以提高CHB的中医诊治水平。
Abstract:
At present, there is no unified standard for the classification of TCM syndromes in chronic hepatitis B (CHB). Generally, it is generally considered to include damp-heat internal syndrome, liver depression and spleen deficiency syndrome, liver and kidney yin deficiency syndrome, blood stasis obstruction syndrome, spleen and kidney yang deficiency 5 kinds of certificates. In recent years, a large number of studies have found that the traditional Chinese medicine syndrome of CHB and unbound bilirubin (IBIL), total bilirubin (TBIL), γ-glutamyl transpeptidase (GGT), HBsAg, HBeAg, HBV-DNA, the body are some correlations among immune status, cytokines, liver pathology and imaging indicators. This article reviews the traditional Chinese medicine syndrome types of CHB and their correlation with the above indicators, and aims to provide a reference for the objective study of the syndrome differentiation of CHB to improve the diagnosis and treatment of CHB.

参考文献/References:

[1]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南（2015更新版）[J].肝脏,2015,20(12):915-932. [2]中华中医药学会肝胆病专业委员会,中国民族医药学会肝病专业委员会,高月球.慢性乙型肝炎中医诊疗指南（2018年版）[J].中西医结合肝病杂志,2019,29(1):97-102. [3]陈少芳,郭明章,鲁玉辉.慢性乙型肝炎中医证型分布规律探析[J].福建中医药大学学报,2014,24(6):1-3,6. [4]中华中医药学会肝胆病分会.病毒性肝炎中医辨证标准（2017年版）[J].中西医结合肝病杂志,2017,27(3):193-194. [5]姜楠,李钦桓.慢性乙型肝炎中医证型与临床检验指标相关性研究[J].双足与保健,2018,27(19):183-184. [6]黄继琴.慢性乙型肝炎中医证型与临床检验指标相关性研究[J].光明中医,2018,33(6):767-768,798. [7]李琦,高宇,赵立铭,等.慢性乙型肝炎中医证型与检验医学指标相关性分析[J].检验医学与临床,2016,13(13):1794-1797. [8]杨振,施卫兵,余金花,等.HBeAg阴性慢性乙型肝炎不同ALT水平中医证型分布特点及与病毒载量关系的研究[J].中医药临床杂志,2015,27(4):484-486. [9]夏先艳.慢性乙型肝炎患者中医辨证分型与肝脏病理及病毒学指标、T细胞亚群的相关性的研究[D].安徽中医药大学,2018. [10]陈剑.HBeAg阴性慢性乙型肝炎中医证型与HBsAg定量相关性研究[D].福建中医药大学,2014. [11]罗泽民,丁维俊,张衡,等.中医药与免疫学研究[J].中国中医基础医学杂志,2008(1):68-70. [12]严颖,朱肖鸿,傅淑艳,等.慢性乙型肝炎病毒携带者细胞免疫功能与中医证型及影响因素相关性研究[J].浙江中西医结合杂志,2018,28(9):743-746. [13]阮连国.慢性乙型肝炎中医证型与细胞免疫和肝脾调补方对细胞免疫影响研究[D].湖北中医药大学,2018. [14]Li MH,Zhang D,Zhang L,et al.RationsofT-helper 2cellstoT-helper 1cellsand cytokinelevelsin patientswith hepatitisB[J].ChinMedJ(Engl),2017,130(15):1810-1815. [15]张振宇,黄衍松,李伟冰,等.慢性乙型肝炎中医证型与患者细胞免疫功能关系研究[J].中西医结合肝病杂志,2018,28(1):8-10. [16]罗俊华,曹秋实.HBeAg阴性慢性乙型肝炎中医证型与T淋巴细胞亚群及IL-4、IFN-γ相关性研究[J].云南中医学院学报,2014,37(4):1-3,8. [17]刘丽丽,张国梁,刘永华,等.慢性乙型肝炎患者中医证型与ALT、HBV DNA及肝组织病理的关系[J].世界中医药,2017,12(3):562-565,569. [18]张国梁,万和荷,刘丽丽,等.慢性乙型肝炎患者肝组织中程序性死亡分子-1表达与肝脏病理及中医证型的相关性研究[J].中西医结合肝病杂志,2014,24(6):324-327,392. [19]陈晓玲.剪切波弹性成像与慢性乙型肝炎中医证型的相关性研究[D].南京中医药大学,2016. [20]邓敏君,陈乐,赖媛媛.实时剪切波弹性成像对慢性乙型肝炎中医证型的相关性及疗效评价[J].现代医药卫生,2017,33(21):3297-3298. [21]沈立松,周韵娴.肝脏纤维化的血清学标志物检测的现状和展望[J].中华检验医学杂志,2014,37(2):93-95.

相似文献/References:

[1]林晓岚,郑丽花,陈苑莉,等.微信随访对慢性乙型肝炎患者抗病毒治疗效果和 生活质量的影响研究[J].医学信息,2018,31(10):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
　LIN Xiao-lan,ZHENG Li-hua,CHEN Yuan-li,et al.Effect of WeChat Follow-up on Antiviral Treatment and Quality of Life in Patients with Chronic Hepatitis B[J].Medical Information,2018,31(03):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
[2]宋 宁,唐丽明,杜红跃,等.基于聚类分析的糖尿病胃轻瘫中医证型分布研究[J].医学信息,2022,35(11):97.[doi:10.3969/j.issn.1006-1959.2022.11.025]
　SONG Ning,TANG Li-ming,DU Hong-yue,et al.Distribution of TCM Syndromes of Diabetic Gastroparesis Based on Cluster Analysis[J].Medical Information,2022,35(03):97.[doi:10.3969/j.issn.1006-1959.2022.11.025]
[3]林晓岚,陈苑莉.慢性乙型肝炎患者治疗依从性及其对生活质量的影响[J].医学信息,2018,31(13):168.[doi:10.3969/j.issn.1006-1959.2018.13.052]
　LIN Xiao-lan,CHEN Yuan-li.Treatment Compliance of Patients with Chronic Hepatitis B and its Influence on Quality of Life[J].Medical Information,2018,31(03):168.[doi:10.3969/j.issn.1006-1959.2018.13.052]
[4]陈 欢,李秀惠.急、慢性乙型肝炎及乙肝肝硬化患者 肝功能及血脂水平分析[J].医学信息,2019,32(12):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
　CHEN Huan,LI Xiu-hui.Analysis of Liver Function and Blood Lipid Levels in Patients with Acute, Chronic Hepatitis B and Hepatitis B Cirrhosis[J].Medical Information,2019,32(03):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
[5]吴 刚,吴锦瑜.HBeAg阴性慢性乙型肝炎患者血清25-羟基维生素D3的检测及临床意义[J].医学信息,2018,31(19):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
　WU Gang,WU Jin-yu.Detection and Clinical Significance of Serum 25-hydroxyvitamin D3 in Patients with HBeAg-negative Chronic Hepatitis B[J].Medical Information,2018,31(03):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
[6]叶向荣.恩替卡韦治疗慢性乙型肝炎病毒感染的临床价值评价[J].医学信息,2018,31(22):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]
　YE Xiang-rong.Clinical Evaluation of Entecavir in Treatment of Patients with Chronic Hepatitis B Virus Infection[J].Medical Information,2018,31(03):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]
[7]汪晓凤,邵和军.慢性乙型肝炎抗病毒治疗进展[J].医学信息,2019,32(04):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
　WANG Xiao-feng,SHAO He-jun.Progress in Antiviral Therapy for Chronic Hepatitis B[J].Medical Information,2019,32(03):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
[8]傅 蕊,李士欣,周国强,等.床旁超声预测慢性乙型肝炎患者胃镜检查围麻醉期误吸风险的临床价值[J].医学信息,2019,32(08):123.[doi:10.3969/j.issn.1006-1959.2019.08.035]
　FU Rui,LI Shi-xin,ZHOU Guo-qiang,et al.Clinical Value of Bedside Ultrasound in Predicting the Risk of Aspiration during Perioperative Anesthesia in Patients with Chronic Hepatitis B[J].Medical Information,2019,32(03):123.[doi:10.3969/j.issn.1006-1959.2019.08.035]
[9]张媛媛,徐 曼.慢性乙型肝炎患者e抗原消失的临床特点[J].医学信息,2019,32(10):105.[doi:10.3969/j.issn.1006-1959.2019.10.033]
　ZHANG Yuan-yuan,XU Man.Clinical Features of e Antigen Disappearance in Patients with Chronic Hepatitis B[J].Medical Information,2019,32(03):105.[doi:10.3969/j.issn.1006-1959.2019.10.033]
[10]罗 丹,梁惠卿,吴耀南.吴耀南教授基于“伏邪”理论治疗慢性乙肝的验案举隅[J].医学信息,2019,32(19):158.[doi:10.3969/j.issn.1006-1959.2019.19.052]
[11]周腾腾,郑 莹,梁恵卿,等.蛋白质组学在慢性乙型肝炎常见中医证型中的研究[J].医学信息,2019,32(20):30.[doi:10.3969/j.issn.1006-1959.2019.20.009]
　ZHOU Teng-teng,ZHENG Ying,LIANG Hui-qing,et al.Study on Proteomics in Common TCM Syndromes of Chronic Hepatitis B[J].Medical Information,2019,32(03):30.[doi:10.3969/j.issn.1006-1959.2019.20.009]

更新日期/Last Update: 2020-02-01